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Background
This project will empower cancer patients to address
their substance use by establishing an evidence-based
strategy for identifying and managing substance use dur-
ing cancer treatment.
The question is: Does the proactive identification and
management of substance use in oncology patients
improve specific patient outcomes such as quality of life,
treatment adherence, and reduction in treatment
complications?
A multidisciplinary team identified substance use as a
contributing factor in several adverse patient outcomes.
Further research revealed that there are currently no
evidence-based standards to guide the care of patients
with alcohol and illicit substance use (AISU) who are
diagnosed with cancer. AISU during cancer treatment
significantly worsens quality of life outcomes, including
problems with pain, sleep, dyspnea, total distress, anxi-
ety, coping, shortness of breath, diarrhea, poor emo-
tional functioning, fatigue and poor appetite[1-4]. AISU
in cancer patients may also cause significant safety risks
in the short and long term[5-9] and increased mortality
[10]. After completing a literature review and an
exhaustive needs assessment, the team developed a pro-
gram to implement Screening, Brief Intervention, and
Referral to Therapy (SBIRT) in the outpatient radiation
oncology department. The implementation plan includes
motivational interviewing training, clinical pathways,
and risk-based intervention toolkits that will incorporate
oncology-specific resources.
Conclusions
AISU in cancer patients is a threat to safety and quality
of life, and patients who use substances during cancer
treatment represent an opportunity to improve wellness
in a vulnerable population. A program that incorporates
the use of SBIRT as part of routine patient care should
improve both cancer-specific and all-cause patient out-
comes and is critical to patient safety.
Material and methods
Three evidence-based methods will be implemented to
address substance use in cancer patients. Inter-profes-
sional instructional design will be provided to nurses
and resident physicians to prepare front-line staff to
implement a screening, brief intervention, and referral
to therapy (SBIRT) program. This instruction will con-
sist of SBIRT-focused motivational interviewing training
utilizing standardized patients and coaching support.
Following this training, staff will implement risk-based
clinical pathways based on validated assessment instru-
ments. Finally, oncology-specific toolkits will be imple-
mented, which will include referral instructions and
resources, oncology-specific risk sheets, and validated
SBIRT educational items.
Results
Nurses and residents will complete surveys regarding
their knowledge, skills, and attitudes. Screening, brief
intervention, and referral rates will also be gathered
retrospectively.
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